Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPR.L Regulatory News (CPR)

  • There is currently no data for CPR

Interim Management Statement

3 Feb 2009 07:00

RNS Number : 6685M
Carpetright PLC
03 February 2009
 



Carpetright plc

Interim Management Statement

Carpetright plc, Europe's leading specialist carpet and floor coverings retailer, today publishes its Interim Management Statement for the 13 weeks to 31 January 2009.

Group sales decreased by 9.0%, with the store base at 696 at the period end.

The UK and Republic of Ireland recorded a total sales decrease of 13.2%, which included a 2.2% contribution from the Sleepright business (acquired on 5 December 2008). Like-for-like sales (excluding Sleepright) for the 13 weeks were down 15.9%. Total sales in the five weeks to 31 January were up 7.9% including Sleepright. Like-for-like sales (excluding Sleepright) were down 2.9%. Footnote 1.

Within the UK and Republic of Ireland, five stores opened during the period and one was closed, increasing the number of outlets to 565, including 60 concessions and 38 Storey stores. Sleepright is trading from 102 outlets, of which all except two are located within existing stores.

Our business in the Rest of Europe (The Netherlands, Belgium and Polandcontinues to make progress. Sales in local currency increased by 10.1%with like-for-like sales down 0.6%. There has been one new store opened in Poland, bringing the total store base to 129 in the Rest of Europe.

There have been no significant changes to the financial position of the Group since the publication of the Interim Results on 16 December 2008.

Lord Harris of Peckham, Chairman and Chief Executive, said:

"As I have said before, the UK trading environment is more difficult than at any time in my working life, with constant news flow of financial turmoil and redundancies. Until we are able to see some confidence in the economy return, trading will continue to be challenging. Sales in January are an improvement on the trends seen in November and December. Our gross margin remains level with last year, in line with our expectations. 

I am pleased with the first few weeks of Sleepright trading. We have now converted all the retail systems to the Carpetright standard and are focusing on enhancing the offer through improved service and pricing. We will open a further 12 Sleepright concessions in the final quarter of the financial year. I remain confident this will prove to be an excellent acquisition for the Group.

Trading in Rest of Europe has not been immune from the current instability in world financial markets, and the rate of growth has slowed. However we continue to grow the business and increase our market share.

Whilst these are difficult times we continue to trade cash positively. The Group remains strongly positioned to extend its market leading position when trading conditions improve."

The Group will report its pre-close trading update on 28 April 2009.

Footnote 1 : January 2009 = 5 weeks from 30 December 2008 to 31 January 2009 ; January 2008 = 5 weeks from 23 December 2007 to 26 January 2008.

Analyst conference call

Lord Harris and Neil Page will host a conference call for analysts at 08.15am this morning. 

The dial in number is +44 (0) 203 003 2666, with a password "Carpetright". 

Thereafter, for further enquiries please contact:

Carpetright plc

Lord Harris of Peckham, Chairman and Chief Executive

Neil Page, Group Finance Director

Tel: 01708 802000

Citigate Dewe Rogerson

Kevin Smith / Lindsay Noton

Tel: 020 7638 9571

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSEFWESUSELE
Date   Source Headline
8th Nov 20174:35 pmRNSPrice Monitoring Extension
31st Oct 20171:43 pmRNSTotal Voting Rights
24th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:34 pmRNSBlock listing Interim Review
7th Sep 201712:48 pmRNSResult of AGM
2nd Aug 20174:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20174:35 pmRNSPrice Monitoring Extension
28th Jul 201710:15 amRNSAnnual Financial Report
13th Jul 20179:00 amRNSAdditional Listing
11th Jul 20174:55 pmRNSDirector/PDMR Shareholding
29th Jun 20174:40 pmRNSSecond Price Monitoring Extn
29th Jun 20174:35 pmRNSPrice Monitoring Extension
27th Jun 20177:00 amRNSFull Year Results
25th Apr 20177:00 amRNSTrading Update
11th Apr 20173:08 pmRNSDirector/PDMR Shareholding
7th Apr 20173:08 pmRNSAdditional Listing
31st Mar 201711:56 amRNSBlock listing Interim Review
9th Mar 20171:38 pmRNSDirector/PDMR Shareholding
23rd Feb 20179:47 amRNSHolding(s) in Company
10th Feb 20172:41 pmRNSDirector/PDMR Shareholding
9th Feb 20174:44 pmRNSDirector/PDMR Shareholding
31st Jan 20177:00 amRNSQ3 Trading Update
27th Jan 20173:35 pmRNSHolding(s) in Company
23rd Jan 201712:13 pmRNSHolding(s) in Company - Replacement for RNS 6593U
19th Jan 20174:32 pmRNSHolding(s) in Company
19th Jan 20174:28 pmRNSHolding(s) in Company
30th Dec 20164:01 pmRNSDirector/PDMR Shareholding
20th Dec 20169:51 amRNSHolding(s) in Company
20th Dec 20169:46 amRNSHolding(s) in Company
13th Dec 20167:00 amRNSInterim Results Announcement
9th Nov 20164:27 pmRNSHolding(s) in Company
8th Nov 20165:58 pmRNSDirector/PDMR Shareholding
26th Oct 20163:57 pmRNSDirector/PDMR Shareholding
25th Oct 20167:00 amRNSTrading Update & Analyst Site Visit
10th Oct 201612:20 pmRNSDirector/PDMR Shareholding
30th Sep 20165:01 pmRNSBlock listing Interim Review
15th Sep 201611:51 amRNSHolding(s) in Company
13th Sep 20161:30 pmRNSDirector/PDMR Shareholding
7th Sep 20163:11 pmRNSDirector/PDMR Shareholding
7th Sep 20161:49 pmRNSResult of AGM
16th Aug 20161:46 pmRNSHolding(s) in Company
9th Aug 201612:15 pmRNSDirector/PDMR Shareholding
29th Jul 201610:21 amRNSAnnual Financial Report
29th Jul 20169:34 amRNSHolding(s) in Company
13th Jul 20162:50 pmRNSDirector/PDMR Shareholding
12th Jul 201612:07 pmRNSSecond Price Monitoring Extn
12th Jul 201612:02 pmRNSPrice Monitoring Extension
5th Jul 201612:10 pmRNSHolding(s) in Company
28th Jun 20167:00 amRNSFull Year Results
11th May 201610:03 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.